These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2232153)
1. [Cardiotoxicity study of ME2303 with the interval intravenous injections to rats]. Aoyama M; Kato S; Kodama I; Toyama J; Watanabe T; Kawaoto H; Asaoka H; Kurebe M Jpn J Antibiot; 1990 Jul; 43(7):1230-7. PubMed ID: 2232153 [TBL] [Abstract][Full Text] [Related]
2. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine. Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976 [TBL] [Abstract][Full Text] [Related]
3. Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4'-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissues. Cummings J; Willmott N; More I; Kerr DJ; Morrison JG; Kaye SB Biochem Pharmacol; 1987 May; 36(9):1521-6. PubMed ID: 3579988 [TBL] [Abstract][Full Text] [Related]
4. Differential long-term subcellular responses in heart and liver to adriamycin stress. Exogenous L-carnitine cardiac and hepatic protection. Zeidán Q; Strauss M; Porras N; Anselmi G J Submicrosc Cytol Pathol; 2002 Jul; 34(3):315-21. PubMed ID: 12408365 [TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration. Saad SY; Najjar TA; Alashari M J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649 [TBL] [Abstract][Full Text] [Related]
6. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment. Deepa PR; Varalakshmi P Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121 [TBL] [Abstract][Full Text] [Related]
7. Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats. Morishima I; Matsui H; Mukawa H; Hayashi K; Toki Y; Okumura K; Ito T; Hayakawa T Life Sci; 1998; 63(7):511-21. PubMed ID: 9718077 [TBL] [Abstract][Full Text] [Related]
8. Long-lasting effect of dexrazoxane against anthracycline cardiotoxicity in rats. Della Torre P; Podesta A; Pinciroli G; Iatropoulos MJ; Mazué G Toxicol Pathol; 1996; 24(4):398-402. PubMed ID: 8864181 [TBL] [Abstract][Full Text] [Related]
9. Astragalus Improved Cardiac Function of Adriamycin-Injured Rat Hearts by Upregulation of SERCA2a Expression. Su D; Li HY; Yan HR; Liu PF; Zhang L; Cheng JH Am J Chin Med; 2009; 37(3):519-29. PubMed ID: 19606512 [TBL] [Abstract][Full Text] [Related]
10. Impact of ellagic acid on adriamycin-induced testicular histopathological lesions, apoptosis, lipid peroxidation and sperm damages. Çeribaşı AO; Sakin F; Türk G; Sönmez M; Ateşşahin A Exp Toxicol Pathol; 2012 Nov; 64(7-8):717-24. PubMed ID: 21295454 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis in young rats with adriamycin-induced cardiomyopathy--comparison with pirarubicin, a new anthracycline derivative. Koh E; Ueda Y; Nakamura T; Kobayashi A; Katsuta S; Takahashi H Pediatr Res; 2002 Feb; 51(2):256-9. PubMed ID: 11809923 [TBL] [Abstract][Full Text] [Related]
12. [A study of the effect of (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic, on reproduction. II. Its teratogenicity in rats and rabbits]. Kurebe M; Asaoka H; Moriguchi M; Hata T; Okano K; Ito M Jpn J Antibiot; 1986 Feb; 39(2):477-506. PubMed ID: 3712754 [TBL] [Abstract][Full Text] [Related]
13. Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat. Cirillo R; Sacco G; Venturella S; Brightwell J; Giachetti A; Manzini S J Cardiovasc Pharmacol; 2000 Jan; 35(1):100-8. PubMed ID: 10630739 [TBL] [Abstract][Full Text] [Related]
14. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. El-Shitany NA; El-Haggar S; El-desoky K Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity. Jackson JA; Reeves JP; Muntz KH; Kruk D; Prough RA; Willerson JT; Buja LM Am J Pathol; 1984 Oct; 117(1):140-53. PubMed ID: 6486242 [TBL] [Abstract][Full Text] [Related]
16. Fetal rat hearts do not display acute cardiotoxicity in response to maternal Doxorubicin treatment. Gziri MM; Pokreisz P; De Vos R; Verbeken E; Debiève F; Mertens L; Janssens SP; Amant F J Pharmacol Exp Ther; 2013 Sep; 346(3):362-9. PubMed ID: 23792410 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin. Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J Cancer Chemother Pharmacol; 1995; 35(3):257-61. PubMed ID: 7805186 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Yilmaz S; Atessahin A; Sahna E; Karahan I; Ozer S Toxicology; 2006 Feb; 218(2-3):164-71. PubMed ID: 16325981 [TBL] [Abstract][Full Text] [Related]
19. The protective effect of melatonin on adriamycin-induced acute cardiac injury. Koçak G; Erbil KM; Ozdemir I; Aydemir S; Sunar B; Tuncel M; Atalay S Can J Cardiol; 2003 Apr; 19(5):535-41. PubMed ID: 12717489 [TBL] [Abstract][Full Text] [Related]
20. Toxicological studies on (2"R)-4'-tetrahydropyranyladriamycin, a new antitumor antibiotic. Chronic toxicity study in rats. Tone H; Shirai M; Danks AP; Lee P; Finn JP; Ashby R Jpn J Antibiot; 1986 Feb; 39(2):403-28. PubMed ID: 3712751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]